Financial reports
10-Q
2024 Q1
Quarterly report
14 Feb 24
10-K
2023 FY
Annual report
19 Dec 23
10-Q
2023 Q3
Quarterly report
14 Aug 23
10-Q
2023 Q2
Quarterly report
15 May 23
10-Q
2023 Q1
Quarterly report
14 Feb 23
10-K
2022 FY
Annual report
20 Dec 22
10-Q
2022 Q3
Quarterly report
12 Aug 22
10-Q
2022 Q2
Quarterly report
13 May 22
10-Q
2022 Q1
Quarterly report
15 Feb 22
NT 10-Q
Notice of late quarterly filing
14 Feb 22
Current reports
8-K
Entry into a Material Definitive Agreement
20 Mar 24
8-K/A
Entry into a Material Definitive Agreement
6 Mar 24
8-K
Know Labs’ Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research Study
6 Mar 24
8-K
Know Labs Secures U.S. $12 Million Funding for Company’s Further Execution
29 Feb 24
8-K
Know Labs Announces the KnowU™, its Wearable Non-Invasive Continuous Glucose Monitor
27 Feb 24
8-K
Know Labs, Inc. Reports First Quarter FY2024 Results
14 Feb 24
8-K
Regulation FD Disclosure
14 Dec 23
8-K
Departure of Directors or Certain Officers
1 Dec 23
8-K
Departure of Directors or Certain Officers
8 Nov 23
8-K
Regulation FD Disclosure
31 Oct 23
Registration and prospectus
424B3
Prospectus supplement
12 Apr 24
S-1/A
IPO registration (amended)
9 Apr 24
S-1
IPO registration
28 Mar 24
424B5
Prospectus supplement for primary offering
20 Mar 24
S-3/A
Shelf registration (amended)
5 Jan 24
S-3
Shelf registration
22 Dec 23
424B4
Prospectus supplement with pricing info
28 Sep 23
S-1/A
IPO registration (amended)
25 Sep 23
FWP
Free writing prospectus
20 Sep 23
S-1/A
IPO registration (amended)
19 Sep 23
Proxies
DEF 14A
Definitive proxy
4 Aug 23
DEFA14A
Additional proxy soliciting materials
5 Aug 22
DEF 14A
Definitive proxy
5 Aug 22
PRE 14A
Preliminary proxy
26 Jul 22
DEF 14A
Definitive proxy
1 Sep 21
PRE 14A
Preliminary proxy
20 Aug 21
DEF 14C
Information statement
19 May 15
PRE 14C
Preliminary information
7 May 15
DEF 14A
Definitive proxy
3 Jul 13
PRE 14A
Preliminary proxy
21 Jun 13
Other
EFFECT
Notice of effectiveness
17 Apr 24
EFFECT
Notice of effectiveness
12 Jan 24
CORRESP
Correspondence with SEC
9 Jan 24
UPLOAD
Letter from SEC
29 Dec 23
EFFECT
Notice of effectiveness
27 Sep 23
CORRESP
Correspondence with SEC
22 Sep 23
CORRESP
Correspondence with SEC
22 Sep 23
UPLOAD
Letter from SEC
8 Sep 23
EFFECT
Notice of effectiveness
14 Dec 22
CORRESP
Correspondence with SEC
9 Dec 22
Ownership